Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP950822.RAUjMcmkdV_8NtE7WRdp3puGC9ODBG9uL6VHcFCo06ZA0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP950822.RAUjMcmkdV_8NtE7WRdp3puGC9ODBG9uL6VHcFCo06ZA0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP950822.RAUjMcmkdV_8NtE7WRdp3puGC9ODBG9uL6VHcFCo06ZA0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP950822.RAUjMcmkdV_8NtE7WRdp3puGC9ODBG9uL6VHcFCo06ZA0130_provenance.
- NP950822.RAUjMcmkdV_8NtE7WRdp3puGC9ODBG9uL6VHcFCo06ZA0130_assertion description "[we started a prospective, open label trial of retreatment of very-difficult-to-treat genotype 1 chronic hepatitis C patients (CHC) patients, who had failed to respond to the (Peg-IFN/RBV), with a triple therapy consisting in these same antivirals plus thalidomide 200 mg/day (the TRITAL study).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP950822.RAUjMcmkdV_8NtE7WRdp3puGC9ODBG9uL6VHcFCo06ZA0130_provenance.
- NP950822.RAUjMcmkdV_8NtE7WRdp3puGC9ODBG9uL6VHcFCo06ZA0130_assertion evidence source_evidence_literature NP950822.RAUjMcmkdV_8NtE7WRdp3puGC9ODBG9uL6VHcFCo06ZA0130_provenance.
- NP950822.RAUjMcmkdV_8NtE7WRdp3puGC9ODBG9uL6VHcFCo06ZA0130_assertion SIO_000772 22217345 NP950822.RAUjMcmkdV_8NtE7WRdp3puGC9ODBG9uL6VHcFCo06ZA0130_provenance.
- NP950822.RAUjMcmkdV_8NtE7WRdp3puGC9ODBG9uL6VHcFCo06ZA0130_assertion wasDerivedFrom befree-2016 NP950822.RAUjMcmkdV_8NtE7WRdp3puGC9ODBG9uL6VHcFCo06ZA0130_provenance.
- NP950822.RAUjMcmkdV_8NtE7WRdp3puGC9ODBG9uL6VHcFCo06ZA0130_assertion wasGeneratedBy ECO_0000203 NP950822.RAUjMcmkdV_8NtE7WRdp3puGC9ODBG9uL6VHcFCo06ZA0130_provenance.
- befree-2016 importedOn "2016-02-19" NP950822.RAUjMcmkdV_8NtE7WRdp3puGC9ODBG9uL6VHcFCo06ZA0130_provenance.